Literature DB >> 10934168

Rapid development of vein graft atheroma in ApoE-deficient mice.

H Dietrich1, Y Hu, Y Zou, U Huemer, B Metzler, C Li, M Mayr, Q Xu.   

Abstract

Several animal models manifesting lesions resembling neointimal hyperplasia of human vein grafts have been developed, but no spontaneous atheromatous lesions in their vein grafts have been observed. We developed and here characterize a new animal model of vein graft atheroma, a maturated atherosclerotic plaque, in apoE-deficient mice. The lesion displayed classical complex morphological features and heterogeneous cellular compositions and consisted of a fibrous cap, infiltrated mononuclear cells, foam cells, cholesterol crystal structure, necrotic core with calcification, and neovasculature. Cell component analysis revealed smooth muscle cells (SMCs) localized in the cap region, macrophages which made up a large portion of the lesions, and CD4+ T cells scattered under the cap. Importantly, apoptotic/necrotic cells determined by TUNEL assay in vein grafts into apoE-/- mice were significantly higher than wild-type mice, although a similar number of proliferating cell nuclear antigen-positive cells in both types of lesions was found. Interestingly, vascular SMCs cultivated from aortas of apoE-deficient mice showed a high rate of spontaneous apoptosis/necrosis and a higher rate of cell death stimulated by a nitric oxide donor, sodium nitroprusside, H(2)O(2), and oxidized low density lipoprotein (LDL), although no difference in proliferation of both SMCs incubated with platelet-derived growth factor, angiotensin II, LDL, and oxidized LDL was seen. Thus, the pathogenic mechanisms of vein graft atheroma involve increased intimal cell death initiated by biomechanical stress and amplified by hypercholesterolemia, which leads to continuous recruitment of blood mononuclear cells to constitute atheromatous lesions. This mouse model resembling human vein graft disease has many advantages over other animal models.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10934168      PMCID: PMC1850116          DOI: 10.1016/S0002-9440(10)64576-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

1.  Biomechanical stress-induced apoptosis in vein grafts involves p38 mitogen-activated protein kinases.

Authors:  M Mayr; C Li; Y Zou; U Huemer; Y Hu; Q Xu
Journal:  FASEB J       Date:  2000-02       Impact factor: 5.191

2.  Reduced neointima hyperplasia of vein bypass grafts in intercellular adhesion molecule-1-deficient mice.

Authors:  Y Zou; Y Hu; M Mayr; H Dietrich; G Wick; Q Xu
Journal:  Circ Res       Date:  2000-03-03       Impact factor: 17.367

3.  Atherosclerosis in rabbit vein grafts.

Authors:  R M Zwolak; T R Kirkman; A W Clowes
Journal:  Arteriosclerosis       Date:  1989 May-Jun

4.  The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery.

Authors:  L Campeau; M Enjalbert; J Lespérance; M G Bourassa; P Kwiterovich; S Wacholder; A Sniderman
Journal:  N Engl J Med       Date:  1984-11-22       Impact factor: 91.245

5.  Microsomal lipid peroxidation.

Authors:  J A Buege; S D Aust
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

6.  Cyclic strain stress-induced mitogen-activated protein kinase (MAPK) phosphatase 1 expression in vascular smooth muscle cells is regulated by Ras/Rac-MAPK pathways.

Authors:  C Li; Y Hu; M Mayr; Q Xu
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

7.  Promotion of lymphocyte growth by high density lipoproteins (HDL). Physiological significance of the HDL binding site.

Authors:  G Jürgens; Q B Xu; L A Huber; G Böck; H Howanietz; G Wick; K N Traill
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

8.  Intimal hyperplasia in autogenous vein grafts used for arterial bypass: a canine model.

Authors:  R W Landymore; C E Kinley; C A Cameron
Journal:  Cardiovasc Res       Date:  1985-09       Impact factor: 10.787

9.  Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque.

Authors:  L Jonasson; J Holm; O Skalli; G Bondjers; G K Hansson
Journal:  Arteriosclerosis       Date:  1986 Mar-Apr

10.  Immunocytochemical investigation of atherosclerotic changes observed in aortocoronary bypass vein grafts using monoclonal antibodies.

Authors:  T Tsukada; T Tejima; J Amano; A Suzuki; F Numano
Journal:  Exp Mol Pathol       Date:  1988-04       Impact factor: 3.362

View more
  12 in total

Review 1.  Defining smooth muscle cells and smooth muscle injury.

Authors:  William M Mahoney; Stephen M Schwartz
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

2.  Exacerbated vein graft arteriosclerosis in protein kinase Cdelta-null mice.

Authors:  M Leitges; M Mayr; U Braun; U Mayr; C Li; G Pfister; N Ghaffari-Tabrizi; G Baier; Y Hu; Q Xu
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

3.  Mouse vein graft hemodynamic manipulations to enhance experimental utility.

Authors:  Peng Yu; Binh T Nguyen; Ming Tao; Yingnan Bai; C Keith Ozaki
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

4.  Role of nifedipine and hydrochlorothiazide in MAPK activation and vascular smooth muscle cell proliferation and apoptosis.

Authors:  J Wang; K Liu; H Wang; Z Li; Y Li; S Ping; A S A Bardeesi; Y Guo; Y Zhou; T Pei; L Deng; P Sheng; S Liu; C Li
Journal:  Herz       Date:  2016-11-09       Impact factor: 1.443

5.  Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis.

Authors:  Hyung J Chun; Ziad A Ali; Yoko Kojima; Ramendra K Kundu; Ahmad Y Sheikh; Rani Agrawal; Lixin Zheng; Nicholas J Leeper; Nathan E Pearl; Andrew J Patterson; Joshua P Anderson; Philip S Tsao; Michael J Lenardo; Euan A Ashley; Thomas Quertermous
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

6.  Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice.

Authors:  Yanhua Hu; Zhongyi Zhang; Evelyn Torsney; Ali R Afzal; Fergus Davison; Bernhard Metzler; Qingbo Xu
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

Review 7.  Mouse models of arteriosclerosis: from arterial injuries to vascular grafts.

Authors:  Qingbo Xu
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

8.  Early adaptive responses of the vascular wall during venous arterialization in mice.

Authors:  Stephanie Kwei; George Stavrakis; Masaya Takahas; George Taylor; M Judah Folkman; Michael A Gimbrone; Guillermo García-Cardeña
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

9.  Tetrahydrobiopterin determines vascular remodeling through enhanced endothelial cell survival and regeneration.

Authors:  Ziad A Ali; Ruth Rinze; Gillian Douglas; Yanhua Hu; Qingzhong Xiao; Wei Qi; Eileen McNeill; Christina Bursill; Isaac George; David R Greaves; Qingbo Xu; Keith M Channon
Journal:  Circulation       Date:  2013-09-10       Impact factor: 29.690

10.  Plaque rupture complications in murine atherosclerotic vein grafts can be prevented by TIMP-1 overexpression.

Authors:  Margreet R de Vries; Hans W M Niessen; Clemens W G M Löwik; Jaap F Hamming; J Wouter Jukema; Paul H A Quax
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.